We previously demonstrated that p38MAPK activates p53, resulting in cell death in cerebral endothelial cells,50 glioma cells51 and colorectal cancer cells.20 Therefore, we examined whether lovastatin affects p38MAPK phosphorylation status in MCF‐7 cells. The gene discussed is TP53; the disease is central nervous system cancer.